RECOVER Study of Paxlovid to Treat Long Covid Begins January 2023, Has Implications for ME/CFS
The National Institutes of Health (NIH) announced that the use of Paxlovid to treat Long Covid will be the first treatment to be studied by its $1 billion RECOVER Initiative. […]
NIH launches database to track neurological symptoms associated with COVID-19
A new database will collect information from clinicians about COVID-19-related neurological symptoms, complications, and outcomes as well as COVID-19 effects on pre-existing neurological conditions. The COVID-19 Neuro Databank/Biobank (NeuroCOVID), which […]
Solve M.E. at the Patient-Centered Outcomes Research Institute (PCORI) Annual Meeting in Washington, D.C.
Allison Ramiller (left) before attending the breakout session Patient Perspective: Learnings and Strategies for Partnership in Research (right) that featured PCORI patient partners Sonya Ballentine and Martie Carnie, Al Richmond from Community-Campus Partnerships for […]
Dr. Sadie Whittaker on the NANDS Working Group’s Strategic, Coordinated Approach to ME/CFS
Within any large organization is a system of operating that is best navigated by those who work within it. That’s why the ME/CFS community is lucky to have among its […]
